Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,541 | -1,280 | -621 | -116 | -600 |
| Depreciation Amortization | 10 | 5 | 0 | N/A | 0 |
| Accounts payable and accrued liabilities | 170 | 309 | 27 | 7 | 132 |
| Other Working Capital | 75 | 270 | 81 | -40 | 160 |
| Other Operating Activity | -76 | -343 | 50 | 8 | -52 |
| Operating Cash Flow | $-2,361 | $-1,040 | $-462 | $-140 | $-360 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -64 | -64 | -8 | N/A | 0 |
| Investing Cash Flow | $-64 | $-64 | $-8 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 192 | N/A | N/A | N/A | 7 |
| Debt Repayment | -247 | -116 | N/A | N/A | N/A |
| Common Stock Issued | 10,305 | 8,454 | 8,671 | N/A | N/A |
| Other Financing Activity | -1,865 | 0 | 0 | 0 | 113 |
| Financing Cash Flow | $8,385 | $8,338 | $8,671 | $N/A | $120 |
| Beginning Cash Position | 303 | 303 | 303 | 303 | 540 |
| End Cash Position | 6,262 | 7,536 | 8,504 | 163 | 300 |
| Net Cash Flow | $5,959 | $7,233 | $8,201 | $-140 | $-230 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,361 | -1,040 | -462 | -140 | -360 |
| Capital Expenditure | -64 | -64 | -8 | 0 | N/A |
| Free Cash Flow | -2,426 | -1,104 | -470 | -140 | -360 |